NASDAQ
Adverum Biotechnologies, Inc. (ADVM) has a free cash flow growth of 27.34% as of Friday, May 29, 2026. This represents a 232.67% increase compared to its 12-month average of -20.60%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.